Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CAN Stock Summary
Top 10 Correlated ETFs
CAN
In the News
Canaan Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
SINGAPORE , Feb. 20, 2024 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its financial results for the fourth quarter and full year ended December 31, 2023, before the U.S. market opens on February 27, 2024. The Company's management team will hold a conference call at 8:00 A.M.
7 Speculative Stocks to Double Your Money THIS Year
While investors should probably direct the majority of their market-earmarked funds toward slow-and-steady ideas – à la Warren Buffett – sometimes, we end up with gambling money. And in that case, speculative stocks to double your money might make sense.
7 Blockchain Stock Picks for the Fed's New Growth Cycle
If Federal Reserve Chair Jerome Powell really does reduce interest rates, then forward-looking investors ought to consider blockchain stocks. True, you can always go for the individual cryptocurrencies.
7 Tech Stocks Destined to Follow in Nvidia's Footsteps
Following the remarkable ascent of Nvidia (NASDAQ: NVDA ) last year, it's only natural for investors to consider the top tech stocks to buy for 2024. Yeah, I suppose that NVDA could again be a winner.
7 Hot Stocks That Could Fly if the Fed Goes Dovish in 2024
Based on the latest economic print, the Federal Reserve expects a shift in monetary policy, which undergirds certain stocks for a dovish Fed. It really comes down to the return of the normal way of doing business.
The 7 Hottest Tech Stocks to Watch in 2024
With Nvidia (NASDAQ: NVDA ) skyrocketing to blistering heights in 2023, the question on everyone's mind now is as follows: what will be the hottest tech stocks in 2024? At the start of the new year, it's worth carefully examining this inquiry.
7 Stocks to Buy if the Fed Goes Through With Interest Rate Cuts
While inflation may have been the theme of 2022, disinflation could be the defining label for the outgoing year, thus warranting a closer examination of stocks to buy for lower interest rates. To be sure, you want to be careful about betting too heavily on the monetary policy pivot.
Canaan Inc. (CAN) Q3 2023 Earnings Call Transcript
Canaan Inc. (NASDAQ:CAN ) Q3 2023 Earnings Conference Call November 28, 2023 8:00 AM ET Company Participants Clark Soucy - IR Director Nangeng Zhang - Chairman and CEO James Jin Cheng - CFO Conference Call Participants Lucas Pipes - B. Riley Securities Michael Donovan - H.C.
Canaan (CAN) Reports Q3 Loss, Tops Revenue Estimates
Canaan (CAN) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to earnings of $0.14 per share a year ago.
Canaan Inc. to Report Third Quarter 2023 Financial Results on November 28, 2023
SINGAPORE , Nov. 20, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its financial results for the third quarter ended September 30, 2023, before the U.S. market opens on November 28, 2023. The Company's management team will hold a conference call at 8:00 A.M.
CAN Financial details
CAN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 17.28 | 1.42 | 0.44 | 4.65 | 28 | |
Net income per share | 0.78 | -0.76 | 0.04 | 1.87 | 4.21 | |
Operating cash flow per share | -0.08 | -1.95 | 0.27 | 8.56 | -1.57 | |
Free cash flow per share | -0.24 | -2.01 | 0.26 | 8.33 | -1.66 | |
Cash per share | 1.65 | 0.53 | 0.44 | 2.51 | 4.52 | |
Book value per share | 1.54 | 0.69 | 0.42 | 3.23 | 28.19 | |
Tangible book value per share | 1.54 | 0.69 | 0.42 | 3.23 | 28.19 | |
Share holders equity per share | 1.54 | 0.69 | 0.42 | 3.23 | 28.19 | |
Interest debt per share | 7.04 | 0.17 | 0.07 | 0.03 | 0.27 | |
Market cap | 9.69B | 6.09B | 6.05B | 5.52B | 2.22B | |
Enterprise value | 10.48B | 6.04B | 6B | 5.1B | 1.54B | |
P/E ratio | 79.12 | -55.79 | 936.41 | 17.58 | 3.38 | |
Price to sales ratio | 3.58 | 29.97 | 88.32 | 7.05 | 0.51 | |
POCF ratio | -760.14 | -21.76 | 143.08 | 3.83 | -9.03 | |
PFCF ratio | -257.26 | -21.12 | 150.84 | 3.94 | -8.55 | |
P/B Ratio | 40.2 | 61.54 | 91.41 | 10.17 | 0.5 | |
PTB ratio | 40.2 | 61.54 | 91.41 | 10.17 | 0.5 | |
EV to sales | 3.87 | 29.71 | 87.59 | 6.52 | 0.35 | |
Enterprise value over EBITDA | 39.31 | -41.26 | -178.42 | 17.65 | 4.49 | |
EV to operating cash flow | -822.14 | -21.57 | 141.9 | 3.54 | -6.26 | |
EV to free cash flow | -278.24 | -20.94 | 149.59 | 3.64 | -5.93 | |
Earnings yield | 0.01 | -0.02 | 0 | 0.06 | 0.3 | |
Free cash flow yield | 0 | -0.05 | 0.01 | 0.25 | -0.12 | |
Debt to equity | 4.35 | 0.22 | 0.15 | 0.01 | 0.01 | |
Debt to assets | 0.75 | 0.15 | 0.06 | 0.01 | 0.01 | |
Net debt to EBITDA | 2.96 | 0.36 | 1.49 | -1.44 | -1.98 | |
Current ratio | 1.18 | 3.3 | 1.7 | 2.53 | 8.91 | |
Interest coverage | 4.74 | -66.86 | -70.78 | 0 | 35 | |
Income quality | -0.1 | 0.27 | -0.2 | 0.72 | -3.49 | |
Dividend Yield | 0.07 | 0 | 0 | 0 | 0 | |
Payout ratio | 5.65 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.05 | 0.24 | 0.29 | 0.12 | 0.13 | |
Research and developement to revenue | 0.07 | 0.12 | 0.31 | 0.07 | 0.12 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 1.95 | 0.03 | -0.05 | -0.03 | 0.06 | |
Capex to revenue | -0.01 | -0.04 | -0.03 | -0.05 | 0 | |
Capex to depreciation | -1.9 | -0.19 | -0.05 | -2.67 | -0.42 | |
Stock based compensation to revenue | 0.01 | 1.33 | 0.04 | 0.63 | 0.01 | |
Graham number | 5.2 | 3.44 | 0.63 | 11.64 | 51.67 | |
ROIC | 0.12 | -1.14 | 0.1 | 0.51 | 0.1 | |
Return on tangible assets | 0.09 | -0.77 | 0.04 | 0.36 | 0.14 | |
Graham Net | -3.14 | 0.33 | -0.03 | 0.86 | 6.75 | |
Working capital | 206.71M | 93.7M | 63.48M | 500.21M | 3.55B | |
Tangible asset value | 240.98M | 99.02M | 66.21M | 542.62M | 4.41B | |
Net current asset value | 206.71M | 91.78M | 61.74M | 486.33M | 3.53B | |
Invested capital | 4.35 | 0.22 | 0.15 | 0.01 | 0.01 | |
Average receivables | 95.25M | 79.17M | 750.75K | 574.3K | 36.57M | |
Average payables | 48.84M | 30.7M | 9.94M | 14.11M | 69.42M | |
Average inventory | 422.76M | 306.85M | 31.27M | 80.98M | 819.76M | |
Days sales outstanding | 21.31 | 0.74 | 5.81 | 0.03 | 6.09 | |
Days payables outstanding | 7.85 | 18.65 | 33.31 | 24.51 | 16.14 | |
Days of inventory on hand | 97.29 | 36.92 | 200.81 | 138.82 | 209.77 | |
Receivables turnover | 17.13 | 495.34 | 62.81 | 13.59K | 59.91 | |
Payables turnover | 46.51 | 19.57 | 10.96 | 14.89 | 22.62 | |
Inventory turnover | 3.75 | 9.89 | 1.82 | 2.63 | 1.74 | |
ROE | 0.51 | -1.1 | 0.1 | 0.58 | 0.15 | |
Capex per share | -0.16 | -0.06 | -0.01 | -0.22 | -0.09 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 5.73 | 2.34 | 0.33 | 0.43 | 0.2 | |
Net income per share | 0.27 | -2.61 | -0.51 | -0.65 | -0.47 | |
Operating cash flow per share | 0.62 | -0.98 | 0.52 | -0.07 | 0 | |
Free cash flow per share | 0.62 | -1.01 | 0.52 | -0.07 | 0 | |
Cash per share | 11.73 | 4.22 | 0.43 | 0.39 | 0.24 | |
Book value per share | 28.53 | 26.29 | 3.29 | 2.51 | 2.13 | |
Tangible book value per share | 28.1 | 26.29 | 3.29 | 2.51 | 2.13 | |
Share holders equity per share | 28.53 | 26.29 | 3.29 | 2.51 | 2.13 | |
Interest debt per share | 0.21 | 0.2 | 0.02 | 0.01 | 0.01 | |
Market cap | 3.99B | 2.38B | 450.46M | 361.82M | 310.92M | |
Enterprise value | 2.02B | 1.7B | 381.54M | 298.09M | 272.26M | |
P/E ratio | 21.65 | -1.36 | -1.33 | -0.82 | -0.97 | |
Price to sales ratio | 4.08 | 6.08 | 8.16 | 4.9 | 9.33 | |
POCF ratio | 37.91 | -14.51 | 5.2 | -32.28 | 0 | |
PFCF ratio | 37.91 | -14.12 | 5.2 | -32.28 | 0 | |
P/B Ratio | 0.82 | 0.54 | 0.82 | 0.85 | 0.86 | |
PTB ratio | 0.82 | 0.54 | 0.82 | 0.85 | 0.86 | |
EV to sales | 2.06 | 4.34 | 6.91 | 4.04 | 8.17 | |
Enterprise value over EBITDA | -7.58 | -2.66 | -4.59 | -2.55 | -2.28 | |
EV to operating cash flow | 19.19 | -10.36 | 4.4 | -26.59 | 0 | |
EV to free cash flow | 19.19 | -10.08 | 4.4 | -26.59 | 0 | |
Earnings yield | 0.01 | -0.18 | -0.19 | -0.31 | -0.26 | |
Free cash flow yield | 0.03 | -0.07 | 0.19 | -0.03 | 0 | |
Debt to equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Net debt to EBITDA | 7.4 | 1.06 | 0.83 | 0.54 | 0.32 | |
Current ratio | 7.27 | 8.91 | 6.28 | 3.92 | 3.84 | |
Interest coverage | -13.85 | -81.41 | -82.29 | 0 | 0 | |
Income quality | 2.28 | -0.28 | -0.15 | 0.06 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.15 | 0.41 | 0.32 | 0.36 | 0.66 | |
Research and developement to revenue | 0.12 | 0.57 | 0.35 | 0.24 | 0.51 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.03 | 0 | 0 | 0 | |
Capex to revenue | 0 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | 0 | -0.02 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.11 | 1.04 | 1.57 | -0.15 | 0 | |
Graham number | 13.16 | 39.32 | 6.11 | 6.06 | 4.74 | |
ROIC | -0.01 | -0.1 | -0.15 | -0.26 | -0.24 | |
Return on tangible assets | 0.01 | -0.09 | -0.13 | -0.21 | -0.17 | |
Graham Net | 12.95 | 6.3 | 0.85 | 0.57 | 0.33 | |
Working capital | 4.33B | 3.55B | 437.77M | 321.73M | 258.33M | |
Tangible asset value | 4.8B | 4.41B | 548.12M | 426.14M | 363.44M | |
Net current asset value | 4.31B | 3.53B | 435.18M | 319.51M | 248.54M | |
Invested capital | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Average receivables | 168.96M | 205.5M | 36.54M | 5.05M | 9.94M | |
Average payables | 64.83M | 74.5M | 71.64M | 27.14M | 23.28M | |
Average inventory | 1.48B | 1.42B | 911.27M | 291.3M | 244.63M | |
Days sales outstanding | 31.09 | 16.78 | 0 | 12.31 | 26.41 | |
Days payables outstanding | 3.87 | 16.81 | 23.6 | 17.09 | 16.89 | |
Days of inventory on hand | 157.6 | 218.5 | 271.86 | 170.17 | 190.82 | |
Receivables turnover | 2.89 | 5.36 | 0 | 7.31 | 3.41 | |
Payables turnover | 23.23 | 5.35 | 3.81 | 5.27 | 5.33 | |
Inventory turnover | 0.57 | 0.41 | 0.33 | 0.53 | 0.47 | |
ROE | 0.01 | -0.1 | -0.15 | -0.26 | -0.22 | |
Capex per share | 0 | -0.03 | 0 | 0 | 0 |
CAN Frequently Asked Questions
What is Canaan Inc. stock symbol ?
Canaan Inc. is a CN stock and trading under the symbol CAN
What is Canaan Inc. stock quote today ?
Canaan Inc. stock price is $1.52 today.
Is Canaan Inc. stock public?
Yes, Canaan Inc. is a publicly traded company.